Anesthesiology & Pain Management

Shelter Medicine

Animal Welfare

Aquatic Medicine

Poultry Medicine

Avian & Exotic

Behavior

Dentistry

Dermatology

Emergency & Critical Care

Equine Medicine

Feline Medicine

Geriatric & Palliative Medicine

Infectious Diseases & Epidemiology

Integrative & Holistic Medicine

Cardiology

Diabetes

Endocrinology

Gastroenterology

Neurology

Oncology

Respiratory Medicine

Urology/Nephrology

Internal Medicine

Food Animals

Small Ruminant

Swine

Livestock

Microbiome

Nutrition

One Health

Ophthalmology

Orthopedics

Parasitology

Pathology

Pediatrics

Pharmacology

Preventive Medicine

Radiology

Rehabilitation

Surgery

Theriogenology

Toxicology

Virtual Care

Zoo Medicine

News

All News

Breaking News

Conference News

Expert Interviews

Programs

dvm360 Insights

dvm360 LIVE!

Pet Connections

Product360

The Vet Blast Podcast

Vet Perspectives™

VetXchange®

dvm360IQ

Fetch

All Conferences

Nashville

Kansas City

National Harbor

Long Beach

Charlotte 2026

Flex CE

Flex Home

Articles

Conference Proceedings

On-demand Webinars

Podcasts

Upcoming Webinars 

Fetch On-Demand

Webinars

Business

Associates

Business & Personal Finance

Buying or Selling a Practice

Career Development

Hospital Design

Leadership & Personal Growth

Owners

Personnel Management

Practice Finances

Practice Managers 

Practice Operations

Students

Technicians 

Technology

Wellbeing & Lifestyle

Partners

Awards

Vet Heroes

Publications

Shop 

Subscribe

As 4/20 day approaches, Pet Poison Helpline used its most recent Toxin Tail to warn veterinary professionals and pet parents ahead of the unofficial cannabis holiday 

Gertie the Goose accidentally consumes marijuana joint 

This useful practice can elevate the standard of feline care and allow earlier detection of chronic disease.

Muscle condition scoring in cats

Fellow Safetycall International employees experienced the helpline’s services firsthand

Pet Poison Helpline comes to the rescue for employees’ pets

Lovey presented to the clinic lethargic, with inappetence but consuming plenty of water, and a bulge on her abdomen when lying down

Case study: Splenic mass in 8-year-old labrador retriever 

Videos

In this sneak peek, Dr. Ernie Ward, DVM, CVFT, explains how leaders can model accountability to spark a culture of pride and performance

Building a culture of accountability starts with leadership

Aaron Shaw, OTR/L, CHT, CSCS breaks down key indicators that a professional may be burning out

How to recognize burnout warning signs

Joya Griffin, DVM, DACVD, offers advice for veterinarians with cases of unusual skin disease in cats

Approaching unusual feline skin disease cases

Surgeons at Washington State University’s Veterinary Teaching Hospital removed a pheochromocytoma from a 12-year-old dog named Jessie

Rare tumor removed from canine patient in Washington

dvm360 is the authority of veterinary medicine news, expert insights, animal health and pet care products, research, and regulations for veterinary professionals.


About Us

Fetch DVM360 Conference

Terms and Conditions

Contact Us

Veterinary Podcast

Privacy

Editorial

Do Not Sell My Information

dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care

Facebook

Instagram

LinkedIn

Tiktok

Spotlight

Register for Hands-On Labs at Fetch Nashville

Check out the Fetch On-Demand Catalog

By Role

Practice Manager

Technicians

Subscriptions

dvm360 Newsletter

dvm360 Magazine

1rem

Clinical

The dvm360® pharmacy page is a comprehensive resource for clinical news and insights on the latest veterinary pharmacy. This page consists of articles, videos, interviews that include research on advancements and developments of therapies for veterinary care, and FDA approvals.

#10: What’s going on with xylazine becoming a street drug

On this episode of The Vet Blast Podcast, Kelley Detweiler, a US Drug Enforcement Administration (DEA) and regulatory compliance expert, and Peter Weinstein, DVM, MBA, join host Adam Christman, DVM, MBA, to discuss the emergence of xylazine as a street drug, the implications that has for veterinarians, and what could happen if xylazine were to be declared a controlled substance by the DEA.

We have compiled a countdown of our top Vet Blast Podcast Episodes in 2023, here is number 10

Top Vet Blast Podcast episodes of 2023: #10

Sponsored by Ceva Animal Health, LLC. Head to

and login or create a free CE account and claim your credit after listening to this episode.

In this podcast Dr. Harry Cridge, an ACVIM and ECVIM board-certified specialist in small animal internal medicine, will discuss his approach to the management of pancreatitis in dogs. This podcast will include discussion of Panoquell®-CA1, a novel and innovative solution for neutrophilic inflammation in acute pancreatitis.

Supportive care – intravenous fluids, nutrition, anti-nausea medications, and analgesia

Recall the mechanism of action of Panoquell®-CA1.

Identify potential adverse effects for drugs in the management of pancreatitis.

Develop a treatment plan for a dog with suspected pancreatitis.

PANOQUELL® is a registered trademark of Ishihara Sangyo Kaisha, Ltd.

PANOQUELL®-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141 to 567. It is a violation of federal law to use this product other than as directed in the labeling. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

*IMPORTANT SAFETY INFORMATION: The safe use of PANOQUELL®-CA1 has not been evaluated in dogs with cardiac disease, hepatic failure, or renal impairment; dogs that are pregnant, lactating, or intended for breeding; or puppies under 6 months of age. PANOQUELL®-CA1 should not be used in dogs with a known hypersensitivity to fuzapladib sodium. PANOQUELL®-CA1 is a highly protein-bound drug and its use with other highly protein-bound medications has not been studied. The most common adverse effects in the pilot field study were anorexia, digestive tract disorders, respiratory tract disorders, and jaundice. PANOQUELL®-CA1 is not for use in humans. Limited data is available on the potential teratogenic effects of fuzapladib sodium. Therefore, anyone who is pregnant, breastfeeding, or planning to become pregnant should avoid direct contact with PANOQUELL®-CA1. For additional information on the use of PANOQUELL®-CA1, please refer to the package insert.

See prescribing and product information: 

Learn and earn CE credits online with dvm360 Flex

Podcast CE: Panoquell-CA1 and its role in the management of acute pancreatitis

Sponsored by Elanco Animal Health. Head to

There are many barriers, whether real or perceived, to providing preventive care and treating many common ailments in cats. Clients may be wary of seeking wellness care after they've experienced a high stress veterinary visit. Furthermore, they may worry it will be next to impossible to get their cat to comply with any at home preventive or therapeutic medication. What if we could make this experience completely different for both the patient and the client? This presentation will walk you through how to make your wellness visits and prescribed treatments not just better, but enjoyable for your feline patients. Learn tips and tricks from a behaviorist's point of view on how to keep your feline patients content and compliant with all of their wellness care and keep your clients coming back for more.

Feline veterinary visits frequency of care

How to mitigate feline veterinary visit stressors

Identification of fear, anxiety, stress in cats

Environmental strategies to reduce stress

Low-stress techniques for conducting common wellness visit procedures

Strategies to maximize owner success of delivering prescribed preventive care at home

Learn important environmental and handling stress mitigating strategies for feline veterinary visits.

Understand the principles and practices of conditioning positive emotions for your feline patients.

Using feline behavioral knowledge, identify best options and strategies for delivering preventive and therapeutic care to feline patients.

 Credelio CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations (

) for one month in cats and kittens 8 weeks of age and older and weighing 2.0 pounds or greater. Credelio CAT is also indicated for treatment and control of 

 (black-legged tick) infestations for one month in cats and kittens 6 months of age and older and weighing 2.0 pounds or greater.

 Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. The safety of Credelio CAT has not been established in breeding, pregnant and lactating cats. The effectiveness of Credelio CAT against 

 in kittens less than 6 months of age has not been evaluated. The most frequently reported adverse reactions are weight loss, tachypnea and vomiting. For full prescribing information see Credelio CAT 

Podcast CE: Breaking down behavioral barriers to feline wellness care 

Due in large part to the COVID-19 pandemic, the world has embraced virtual care and telemedicine more than ever before. Jessica Lowe, DVM, MBA, BSc, joins The Vet Blast Podcast to share her experiences with virtual care and how it continues to evolve.

Below is a partial transcript. Listen to the full podcast for more.

: Right now, there's about a two-to-three month waiting period between us getting into a doctor in an in-clinic setting. If the dog has had a little bit of loose bowels, we can talk to them before sending them to you. We can even send them a fecal kit to get their fecal ahead of time...Now you just have to prescribe your dewormer and you're done. You know, we're here to assist and complement the in-person clinic.

How virtual care is changing the landscape of veterinary medicine

Moving the needle in vet med with telehealth and virtual care

On the latest episode of The Vet Blast Podcast, host Adam Christman, DVM, MBA explores the emerging world of electronic prescribing with Elliot Garber, DVM, MPH, MS, DACVPM. They discuss how this can affect workflow and why it has taken so long for this process to make the jump from human to veterinary medicine.

: If you're going to be losing those sales anyway, you don't want to then have to pay your staff to sort through both the fax machine and 5 different online portals from different pharmacies to check the medical records [to] make sure...[it] is a valid prescription. Then, go in and approve it or fax it back or get on the phone to the retail pharmacy and try to reach the pharmacist who can actually talk to you to approve a prescription. So, it's kind of a double burn for the veterinary teams, because not only are they losing the sale of that prescription product, but then they have to lose a bunch of their time dealing with that in an inefficient way too.

Electronic prescribing finally comes to veterinary medicine

How e-prescribing can save time and enhance patient safety

The nutraceutical 4CYTE Epiitalis Forte Dog was previously only available abroad  and is now distributed domestically by epiq Animal Health and Interpath Global.

Supplement for managing canine OA is launched in the US market

OST-HER2 could be a frontline treatment for dogs and humans

New immunotherapy treatment may  delay metastasis in dogs with osteosarcoma

The STAY study is investigating LOY-002, a therapy designed by Loyal to extend healthy lifespans in canines

Clinical trial for Longevity drug meets goal of enrolling 1000 dogs

The FDA has approved the new indication for Zoetis' Simparica Trio

Combination parasiticide receives label extension to include flea tapeworms

Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

Medical management considerations for separation anxiety

Lee Pope, DVM, shared some common compounding pharmaceuticals requests from veterinarians..

Common compounding questions

Veterinarians often have questions about compounded drugs. In an interview with 

, Lee Pope, DVM, a veterinary consultant with Revelation Animal Health, a division of Revelation Pharma, discusses some of the most common inquiries about pharmaceuticals for veterinary patients. By asking these questions, veterinarians are helping to ensure adherence to treatment plans and a more positive patient experience, leading to improved outcomes.

The following is a transcript of the video:

Veterinarians will call and say, ‘Okay, this drug, can you make it into a liquid?’ Can you make it into a chewable tablet? Can you make it into a topical? So, basically, this is what we have FDA approved or are allowed to use. But can you make it in this different formulation for me?

Other requests: Will the pet take it? So it needs to be flavored. Is this flavoring good? Do cats take this flavoring? Do dogs take this flavoring? Do they approve of it? Can it be easily dosed?’ So, just because you can make a compounded into a medication, well, if you're trying to give a cat 15 milliliters of a liquid, nobody's going to be very excited to have to do that. So can it be easily dosed? Is it a volume that we can realistically give to our patient? Can we make scored tablets to where I can easily give a half a tablet, a quarter of a tablet, without turning it into dust?

Can I use this in the office? Can I have this for office use to dispense? Now, that will vary depending on the state, so you have to check with your local regulations on that.

In a dvm360 interview, Lee Pope, DVM, shares what veterinarians most-often request of their patients' medications.

Pharmacology

Latest News